Anne Letsch

Anne Letsch is a Professor at the Faculty of Medicine, Christian-Albrechts-University of Kiel, and serves in a leading clinical and administrative role at the University Medical Center Schleswig-Holstein (UKSH), Campus Kiel. She is the head of the Oncological Center at the Kiel campus and a member of the executive board of the Universitäres Cancer Center SH (UCCSH), the largest interdisciplinary academic cancer center in Schleswig-Holstein. Her work is based in the Department of Internal Medicine II, which specializes in hematology, oncology, stem cell transplantation, and cellular immunotherapy.

• Institution: Christian-Albrechts-University of Kiel
• Hospital Affiliation: University Medical Center Schleswig-Holstein (UKSH)
• Campus: Kiel
• Leadership Roles: Head, Oncological Center Campus Kiel; Member, UCCSH Executive Board

Her research and clinical interests focus on hematological malignancies and advanced cancer therapies. The department under her leadership emphasizes personalized, interdisciplinary treatment through the Karl Lennert Cancer Center (KLC), integrating modern diagnostics and innovative therapies such as CAR-T cell therapy. She is involved in shared decision-making initiatives and patient-centered care, with the clinic being the only hematological-oncological unit in Germany certified under the SHARE TO CARE standard.

The available articles and publications were not listed in the provided text, so no trends can be analyzed at this time. However, the clinical and research environment suggests a strong focus on translational oncology, immunotherapy, and precision medicine.

Anne Letsch has not been mentioned in association with any scientific awards in the provided material.

There is no information available about her advising of students or management of research grants. However, given her senior leadership position and professorial rank, it is likely she mentors junior physicians, researchers, and medical students within the university and hospital setting. The department is actively involved in clinical trials and translational research, suggesting participation in grant-funded projects, though specific details are not provided.

She plays a key role in the University Cancer Center Schleswig-Holstein (UCCSH), a supra-regional interdisciplinary cancer center that integrates clinical care, research, and education across the Kiel and Lübeck campuses. The UCCSH facilitates tumor conferences, molecular tumor boards, and precision oncology programs, with strong emphasis on integrating basic research with clinical application. The department includes specialized units such as the Stem Cell and Immunotherapy Section and the Special Hematological Diagnostics Laboratory, both contributing to cutting-edge patient care and research.